The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

"It is considered more painful than fibromyalgia or giving birth — even more painful than amputating a finger without ...

Drug rashes are a common side effect in people taking antiseizures, antibiotics, or anti-inflammatories. Find out specific ...

To keep your pup safe from heartworm disease and its serious repercussions, review our researched list of the best heartworm ...

Psychiatric medicine hasn’t seen much innovation in recent decades, even as many say that drugs like psilocybin, MDMA, and ...

Such promotion was banned until 1997, when the FDA reluctantly allowed pharmaceutical ads on TV, so long as they gave an accurate accounting of a medicine’s true benefits and risks, including a list ...

A new study found a link between SGLT-2 inhibitors and a significantly lower risk of dementia in people with diabetes. Here's ...

On August 8, 2024, the US Food and Drug Administration (FDA) partially revised the availability of certain glucagon-like peptide 1 (GLP-1) ...

Nonadherence to medication in patients with HFrEF is associated with less improvement and worse health status.

Starting in 2025, Medicare Part D plans will have an annual out-of-pocket maximum of $2,000 for prescription drug benefits. Additionally, beneficiaries will have the option to spread their ...